117 related articles for article (PubMed ID: 27614914)
21. Cytidine 5'-monophosphate (CMP)-induced structural changes in a multifunctional sialyltransferase from Pasteurella multocida.
Ni L; Sun M; Yu H; Chokhawala H; Chen X; Fisher AJ
Biochemistry; 2006 Feb; 45(7):2139-48. PubMed ID: 16475803
[TBL] [Abstract][Full Text] [Related]
22. Studies on the inhibition of sialyl- and galactosyltransferases.
Kleineidam RG; Schmelter T; Schwarz RT; Schauer R
Glycoconj J; 1997 Jan; 14(1):57-66. PubMed ID: 9076514
[TBL] [Abstract][Full Text] [Related]
23. Different reactivity of two brain sialyltransferases towards sulfhydryl reagents. Evidence for a thiol group involved in the nucleotide-sugar binding site of the NeuAc alpha 2-3Gal beta 1-3GalNAc alpha(2-6)sialyltransferase.
Baubichon-Cortay H; Broquet P; George P; Louisot P
Glycoconj J; 1989; 6(1):115-27. PubMed ID: 2485232
[TBL] [Abstract][Full Text] [Related]
24. Structure-based mutagenic analysis of mechanism and substrate specificity in mammalian glycosyltransferases: porcine ST3Gal-I.
Rakic B; Rao FV; Freimann K; Wakarchuk W; Strynadka NC; Withers SG
Glycobiology; 2013 May; 23(5):536-45. PubMed ID: 23300007
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of a fluorescently tagged sialic acid analogue useful for live-cell imaging.
Suzuki K; Ohtake A; Ito Y; Kanie O
Chem Commun (Camb); 2012 Oct; 48(78):9744-6. PubMed ID: 22914432
[TBL] [Abstract][Full Text] [Related]
26. Unliganded and CMP-Neu5Ac bound structures of human α-2,6-sialyltransferase ST6Gal I at high resolution.
Harrus D; Harduin-Lepers A; Glumoff T
J Struct Biol; 2020 Nov; 212(2):107628. PubMed ID: 32971290
[TBL] [Abstract][Full Text] [Related]
27. Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
Biochemistry; 2011 Nov; 50(44):9475-87. PubMed ID: 21913655
[TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.
Sproviero D; Julien S; Burford B; Taylor-Papadimitriou J; Burchell JM
J Biol Chem; 2012 Dec; 287(53):44490-7. PubMed ID: 23275522
[TBL] [Abstract][Full Text] [Related]
29. 3D-QSAR analysis of sialyltransferase inhibitors.
Wang X; Niu Y; Cao X; Zhang L; Zhang LH; Ye XS
Bioorg Med Chem; 2003 Sep; 11(19):4217-24. PubMed ID: 12951152
[TBL] [Abstract][Full Text] [Related]
30. ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines.
Videira PA; Correia M; Malagolini N; Crespo HJ; Ligeiro D; Calais FM; Trindade H; Dall'Olio F
BMC Cancer; 2009 Oct; 9():357. PubMed ID: 19811634
[TBL] [Abstract][Full Text] [Related]
31. Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression.
Kono M; Ohyama Y; Lee YC; Hamamoto T; Kojima N; Tsuji S
Glycobiology; 1997 Jun; 7(4):469-79. PubMed ID: 9184827
[TBL] [Abstract][Full Text] [Related]
32. Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids.
Okajima T; Fukumoto S; Miyazaki H; Ishida H; Kiso M; Furukawa K; Urano T; Furukawa K
J Biol Chem; 1999 Apr; 274(17):11479-86. PubMed ID: 10206952
[TBL] [Abstract][Full Text] [Related]
33. α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues.
Pérez-Garay M; Arteta B; Llop E; Cobler L; Pagès L; Ortiz R; Ferri MJ; de Bolós C; Figueras J; de Llorens R; Vidal-Vanaclocha F; Peracaula R
Int J Biochem Cell Biol; 2013 Aug; 45(8):1748-57. PubMed ID: 23726834
[TBL] [Abstract][Full Text] [Related]
34. Enzymatic basis for N-glycan sialylation: structure of rat α2,6-sialyltransferase (ST6GAL1) reveals conserved and unique features for glycan sialylation.
Meng L; Forouhar F; Thieker D; Gao Z; Ramiah A; Moniz H; Xiang Y; Seetharaman J; Milaninia S; Su M; Bridger R; Veillon L; Azadi P; Kornhaber G; Wells L; Montelione GT; Woods RJ; Tong L; Moremen KW
J Biol Chem; 2013 Nov; 288(48):34680-98. PubMed ID: 24155237
[TBL] [Abstract][Full Text] [Related]
35. Structural Basis for Binding of Fluorescent CMP-Neu5Ac Mimetics to Enzymes of the Human ST8Sia Family.
Volkers G; Lizak C; Niesser J; Rosell FI; Preidl J; Gnanapragassam VS; Horstkorte R; Rademann J; Strynadka NCJ
ACS Chem Biol; 2018 Aug; 13(8):2320-2328. PubMed ID: 30015474
[TBL] [Abstract][Full Text] [Related]
36. A systematic analysis of acceptor specificity and reaction kinetics of five human α(2,3)sialyltransferases: Product inhibition studies illustrate reaction mechanism for ST3Gal-I.
Gupta R; Matta KL; Neelamegham S
Biochem Biophys Res Commun; 2016 Jan; 469(3):606-12. PubMed ID: 26692484
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of CMP-9''-modified-sialic acids as donor substrate analogues for mammalian and bacterial sialyltransferases.
Kajihara Y; Kamitani T; Sato R; Kamei N; Miyazaki T; Okamoto R; Sakakibara T; Tsuji T; Yamamoto T
Carbohydr Res; 2007 Sep; 342(12-13):1680-8. PubMed ID: 17572399
[TBL] [Abstract][Full Text] [Related]
38. Sialyltransferase specificity in selectin ligand formation.
Ellies LG; Sperandio M; Underhill GH; Yousif J; Smith M; Priatel JJ; Kansas GS; Ley K; Marth JD
Blood; 2002 Nov; 100(10):3618-25. PubMed ID: 12393657
[TBL] [Abstract][Full Text] [Related]
39. Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer.
Recchi MA; Hebbar M; Hornez L; Harduin-Lepers A; Peyrat JP; Delannoy P
Cancer Res; 1998 Sep; 58(18):4066-70. PubMed ID: 9751611
[TBL] [Abstract][Full Text] [Related]
40. Critical role of evolutionarily conserved glycosylation at Asn211 in the intracellular trafficking and activity of sialyltransferase ST3Gal-II.
Ruggiero FM; Vilcaes AA; Iglesias-Bartolomé R; Daniotti JL
Biochem J; 2015 Jul; 469(1):83-95. PubMed ID: 25916169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]